Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 11, 2002, Pages 929-935

  Baudouin, Christophe ^a,b   Nordmann, Jean Philippe ^b,c   Denis, Philippe ^d   Creuzot Garcher, Catherine ^e   Allaire, Catherine ^f   Trinquand, Claude ^f  

^a HÔPITAL AMBROISE PARÉ   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^c HÔPITAL TENON   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e HÔPITAL DU BOCAGE   (France)

^f Laboratoire Chauvin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; DRUG PRESERVATIVE; DYE; EYE DROPS; FLUORESCEIN; FLUOROMETHOLONE; HLA DR ANTIGEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG TOLERANCE; FEMALE; FILTERING OPERATION; HUMAN; IMPRESSION CYTOLOGY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PARALLEL DESIGN; PRIORITY JOURNAL; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0036947054     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0581-9     Document Type: Article

References (22)

1. Baudouin C (1996) Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 7:80-86
2. Baudouin C, Haouat N, Brignole F, et al (1992) Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 76:545-549
3. Baudouin C, Garcher C, Haouat N, et al (1994) Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 101:454-460
4. Baudouin C, Pisella PJ, Fillacier K, et al (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Ophthalmology 106:556-563
5. Brignole F, Pisella PJ, De Saint Jean M, et al (2001) Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical ciclosporin A. Invest Ophthalmol Vis Sci 42:90-95
6. Broadway DC, Grierson I, Hitchings R (1993) Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol. 77:590-596
7. Broadway DC, Grierson I, O'Brien C, et al (1994) Adverse effects of topical antiglaucoma medication. Arch Ophthalmol 112:1437-1445
8. Broadway DC, Grierson I, O'Brien C, et al (1994) Adverse effects of topical antiglaucoma medication. Arch Ophthalmol 112:1446-1454
9. Broadway DC, Hitchings R, Grierson I (1995) Topical antiglaucomatous therapy: adverse effects on the conjunctiva and implications for filtration surgery. J Glaucoma 4:136-148
10. Broadway DC, Grierson I, Sturmer J, et al (1996) Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 114:262-267
11. Chang L, Crowston JG, Cordeiro MF, et al (2000) The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol 45:49-68
12. Ihan A, Cvenkel C (2000) Conjunctival epithelium expression of HLA-DR in glaucoma patients and its influence on the outcome of filtration surgery. Br J Ophthalmol 84:648-650
13. Kwok AK, Lam DS, Ng JS, et al (1997) Ocular-hypertensive response to topical steroids in children. Ophthalmology 104:2112-2116
14. Lavin MJ, Worwald RPL, Migdal CS, et al (1990) The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 108:1543-1548
15. Mietz H, Niesen U, Krieglstein GK (1994) The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 232:561-565
16. Nuzzi R, Vercelli A, Finazzo C, et al (1995) Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultra-structural study. Graefes Arch Clin Exp Ophthalmol 233:154-162
17. Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C (2000) Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbit. Ophthalmic Res 32:3-8
18. Sagdic Yalvac I, Gedikoglu G, Karagoz Y, et al (1995) Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol 73:246-248
19. Sherwood MB, Grierson I, Millar L, et al (1989) Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 96:327-335
20. Van Bijsterveld OP (1969) Diagnostic tests in the sicca syndrome. Arch Ophthalmol 82:10
21. Vetrugno M, Quaranta GM, Maino A, et al (2000) A randomized, comparative study of fluorometholone 0.2% and fluorometholone 0.1 % acetate after photorefractive keratectomy. Eur J Ophthalmol 10:39-45
22. Yingpind D, Lin W, Chunling L, et al (1999) Effects of Dexamethasone, Fluorometholone and Florex on intraocular pressure after photorefractive keratectomy. J West China Univ Med Sci 30:205-207